JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurata, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurata, S.-i.

Volume 271, Number 36, Issue of September 6, 1996 pp. 21798-21802
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Sensitization of the HIV-1-LTR upon Long Term Low Dose Oxidative Stress*

(Received for publication, May 6, 1996)

Shun-ichi Kurata

From the Department of Biochemical Genetics, Medical Research Institute, Tokyo Medical and Dental University, Yushima, Bunkyo-ku, Tokyo 113, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Human lymphoid cell lines were transfected with HIV-1-LTR-CAT DNA and permanently transformed cell lines were obtained. These transformed cell lines were treated with 0.01 mM H2O2 for 25 days and the chloramphenicol acetyltransferase (CAT) activities of these cell lines were measured. The CAT activities of transformed cell lines were latent in normal culture conditions, but were activated by retreatment with 0.2 mM H2O2 for 1 h. On treatment with 0.05 mM H2O2 for 1 h, the CAT activity of these cell lines maintained in normal conditions remained latent, whereas cell lines pretreated with 0.01 mM H2O2 for 25 days were greatly activated by this treatment. Here, the HIV-1 promoter seemed latent in normal culture conditions, but it could be activated by a comparatively low concentration (0.05 mM) of H2O2 after treatment with a dilute H2O2 (0.01 mM) for about 1 month. Many patients infected with human immunodeficiency virus 1 (HIV-1) show a long latent period before development of AIDS. During this latent period, their infected cells may be subjected to oxidative stress due to metabolism and physical movement. The present results indicate that oxidative stress may cause activation of the HIV-1 promoter in patients with latent HIV-1.


INTRODUCTION

Almost all patients infected with HIV-11 show a latent period of several years before development of acquired immunodeficiency syndrome (AIDS) (1). The production of HIV-1 has been found to be very low before onset of the disease, although the provirus DNA is inserted into the host cell DNA (2, 3). The latent HIV-1 can be activated by superinfection with another DNA virus such as the cytomegalovirus or herpes virus (4), but little is known about this mechanism of activation of latent HIV-1. On the other hand, the nuclear factor kappa -B (NF-kappa B) is known to be a strong activator of the HIV-1 promoter (5), and activation of NF-kappa B by hydrogen peroxide (H2O2) has been reported (6). These findings suggest that oxidative stress such as hydrogen peroxide and superoxide may be important in the activation of latent HIV-1.

To examine this possibility, we transfected pCD12 (HIV-LTR-CAT) plasmid into human lymphoid cell lines and obtained stable transformants (cf. Refs. 4 and 7). These cell lines showed low CAT activity like latent HIV-1 in normal culture condition. The CAT activity was markedly elevated when these transformant cells were cultured in the presence of 0.2 mM H2O2 for 1 h, but on treatment of 0.05 mM H2O2 the CAT activity remained at a low level. However, when the transformed cells were pretreated with a dilute H2O2 (0.01 mM) for about 25 days, the CAT activity of transformed cell lines could be markedly elevated by retreatment with 0.05 mM H2O2 for 1 h. This activation of the HIV-1 promoter by a comparatively low concentration of H2O2 seems interesting, because patients latently infected with HIV-1 presumably receive various oxidative stresses as results of physical movements and metabolism during the long latency period (8, 9). In the early period of latency, the patients may have only cells of the ``low CAT activity type'' but when they undergo oxidative stress for a long time like cells during a long term culture with a dilute H2O2, the latent virus may be activated and comparatively low oxidative stress may cause marked activation of HIV-1 gene expression. From this view point, our transformed cell lines may act as a good model of lymphoid cells in patients infected with HIV-1 (cf. Refs. 10 and 11).


MATERIALS AND METHODS

Transformation---HL60, U937, and MOLT4 cells were maintained in RPMI 1640 with 10% fetal bovine serum. About 5 × 106 cells were fused with the Escherichia coli DH1 containing plasmid pSV2CAT (109 cells (12)) plus DH1 containing pSV2neo (5 × 107 cells (13)) or DH1 containing plasmid pCD12 (HIV-LTR-CAT, 109 cells (14)) plus DH-1 containing pSV2neo (5 × 107 cells) or mutant pCD12 (5) plus DH1 containing pSV2neo (5 × 107 cells) by the protoplast fusion method (15). For construction of mutant pCD12, 91-bp HaeIII fragment containing two NF-kappa B motif (AGGGACTTTCC and GGGGACTTTCC) was replaced with synthetic 91-bp fragment containing two mutant NF-kappa B motif (ACTCATTTCC and GCTCACTTTCC (cf. Ref. 5)). The medium was changed 18 h after protoplast fusion, and the cells were cultured further for 2 days. Then they were selected with G418 in RPMI 1640 medium. After the selection with G418 for about 3 weeks, permanently transformed clones (HL60CD, U937CD, MOLT4CD (transformed by pCD12) and HL60SV, U937SV, MOLTSV (transformed by pSV2CAT), respectively (cf. Ref. 7)) were obtained. MOLT4CD* cells were obtained after fusion with DH1 cells containing mutant pCD12 plasmid and MOLT4 cells. The insertions of these DNA were investigated previously by Southern hybridization (7).

H2O2 Treatment and CAT Assay

A part of the transformed cell lines were maintained in normal RPMI 1640 and treated with a low concentration of H2O2 (0.01 mM) for 4 h per day for 25 days and maintained with or without 20 mM of N-acetyl-L-cysteine (NAC) for 24 h. These cell lines were treated with H2O2 (0, 0.05, or 0.2 mM) for 1 h and then they were cultured in normal RPMI 1640 for 48 h, collected, and washed with phosphate-buffered saline. Samples of 5 × 105 cells were suspended in 0.25 M Tris-HCl (pH 8.0), and cellular extracts were prepared by five cycles of freezing (-80 °C) and thawing. Chloramphenicol acetyltransferase (CAT) activity was measured by incubating whole cell extracts with 14C-labeled chloramphenicol and 5 mM acetyl coenzyme A at 37 °C for 18 h. Acetylated chloramphenicol was separated from nonacetylated chloramphenicol by ascending thin-layer chromatography (16). Chromatograms were examined and quantitated with a Fuji image analyzer BA100.

Binding of Nuclear Proteins to the NF-kappa B Binding Motif DNA

Nuclear proteins binding to the NF-kappa B binding motif were detected by the Life Technologies, Inc. kit. Briefly, 42-mer DNA containing two NF-kappa B DNA motifs (GGGGACTTTCC) was end-labeled with [gamma -32P]ATP for binding with nuclear extracts. Nuclear extracts were prepared at intervals by the method of Dignam et al. (17) after treatment of the cells with H2O2. Samples of 5 ng of end-labeled DNA fragments were bound with 3 mg of nuclear proteins in a solution of 20 mM Hepes buffer (pH 7.9), 100 mM KCl, 20%(v/v) glycerol, 0.2 mM EDTA, 0.5 mM dithiothreitol, 10 mM MgCl2, 125 mM spermidine, and 3 mg of poly(dI-dC) for 20 min. The preparations were then separated by electrophoresis in 4% polyacrylamide gel in Tris borate-EDTA buffer and autoradiographed. For competition assays, excess amounts of cold 42-mer fragments and a synthetic mutant sequence of the NF-kappa B motif (TCGACAGAATTCACTTTCCGAGAGGCTCGA) (18) were used for binding assays. For supershift assays, 10-fold diluted rabbit antiserum against NF-kappa B (p65) (Santa Cruz Biotechnology) was also added to the binding reaction. The complexes of NF-kappa B motif DNA, nuclear protein, and antibody were identified by electrophoresis as described previously (19).

Binding of Nuclear Proteins with HIV-1-LTR DNA

HIV-LTR DNA was digested with SacI and PvuII to obtain a 120-bp DNA fragment (16). This 120-bp fragment, which contained the NF-kappa B motif, was also end-labeled with [gamma -32P]ATP for binding with nuclear extracts. Band shift assays were performed as described above. After band shift assay, shifted bands were removed and eluted from the gel by electrophoresis and their radioactivities determined. The protein-DNA complexes obtained were immunoprecipitated with anti-NF-kappa B p65 rabbit serum, and the recovery of radioactivity of [32P]-labeled DNA was also determined.


RESULTS AND DISCUSSION

Effects of Short Term Treatment with H2O2 on CAT Activity

Transformed cell lines were obtained by the protoplast fusion method as described previously (7). Three cell lines (HL60, U937, and MOLT4) transformed by pCD12 (HIV-LTR-CAT) plasmid were named HL60CD, U937CD, and MOLT4CD, respectively, and the same cells transformed by pSV2CAT plasmid were named HL60SV, U937SV, and MOLT4SV, respectively (cf. Ref. 7), and MOLT4 cells transformed by mutant pCD12 were named MOLT4CD*. For short term H2O2 treatment, these cell lines were treated with 0, 0.05, or 0.2 mM H2O2 for 1 h, then washed with normal medium (RPMI 1640, 10% fetal bovine serum), and cultured for 48 h. Samples of 5 × 105 of these cells were then used for measurement of CAT activity by thin-layer chromatography (Fig. 1A, part a). The CAT activities were measured as percentage conversion of the acetylated form of chloramphenicol from extracts derived of transformed cell lines. The CAT activities of HL60CD cell line treated with 0, 0.05, and 0.2 mM H2O2 were 0, 5.2, and 65.3%, respectively, and almost the same results were obtained in U937CD and MOLT4CD cell lines (Fig. 1A, part b). It was found that on short term (1 h) H2O2 treatment with a moderate concentration of H2O2 (0.05 mM), the CAT activity of pCD12-transformed cell lines were only weak; however, a high concentration of H2O2 (0.2 mM) treatment resulted in a marked activation of CAT activity (cf. Ref. 6). The CAT activity of pSV2CAT-transformed cells were extremely high and did not change on treatment with H2O2, but the CAT activity of MOLT4CD* was low and did not change on treatment with H2O2 (Fig. 1A).


Fig. 1. CAT assay of transformed cell lines. A, transcriptional activation of HIV-LTR promoter measured by CAT activity after treatment with H2O2. Part a, 5 × 105 cells of each cell line were treated with 0, 0.05, and 0.2 mM H2O2 for 1 h and extracts were separated by thin-layer chromatography, and the CAT activity of each transformed cell line was measured; part b, the percentage conversion of the acetylated form of [14C]chloramphenicol. B, Time course of CAT activation in cells transformed with pCD12 on long term dilute H2O2 (LDH) treatment. Part a, time course of CAT activity of cells treated with LDH measured by thin-layer chromatography; part b, the percentage conversion of the acetylated form of chloramphenicol. C, reduction of CAT activity by NAC (20 mM) after long term (25 days) dilute H2O2 (LDH) treatment. Part a, CAT activity of cells treated with NAC after LDH treatment; part b, the percentage conversion of the acetylated form of chloramphenicol. The percentage conversion of acetylated form of [14C]chloramphenicol was determined as follows; Conversion (%) = counts/min of acetylated form of chloramphenicol/total counts/min × 100.
[View Larger Version of this Image (44K GIF file)]

Effects of Long Term Dilute H2O2 Treatment on CAT Activity

For long term dilute H2O2 treatment, transformed cell lines were treated with 0.01 mM H2O2 for 25 days. At 5-day intervals 0.01 mM H2O2-treated transformed cell lines were collected. The cells were retreated with 0, 0.05, or 0.2 mM of H2O2 for 1 h, washed with normal medium, and cultured for an additional 48 h. The CAT activities of the HL60CD cell line measured as a percentage conversion of the acetylated form of chloramphenicol after short term H2O2 treatment (0, 0.05, 0.2 mM for 1 h) were about 0, 5.2, and 65.3%, respectively (cf. Fig. 1A), but in long term treatment (25 days) the CAT activities were about 7.0, 68.4, and 71.0%, respectively (Fig. 1B). It was found that long term dilute H2O2 treatment (4 h/day for 20 days or more) slightly elevated the CAT activity. And when these cells were retreated by 0.05 mM H2O2 for 1 h, marked elevations of CAT activity were observed. Almost the same results were obtained in U937CD and MOLT4CD cell lines. This sensitization of CAT activity by dilute H2O2 was abolished by the antioxidant (NAC, 20 mM) treatment (Fig. 1C). Marked elevation of CAT activity induced by a moderate concentration (0.05 mM) of H2O2 after long term dilute H2O2 treatment may indicate that the latent HIV-1 promoter in infected cells became sensitive on long term treatment with a low concentration (0.01 mM) of H2O2. In contrast CAT activity of MOLT4CD* cell remained at a low level after long term dilute H2O2 treatment (Fig. 1B; cf. Fig. 1A).

Many patients infected with HIV-1 show a long latency period. If this latency of infected patients corresponds with the ``latency'' of expression from the HIV promoter in transformed cells, sensitization of the HIV-1 promoter in transformed cells in the presence of a low concentration of H2O2 may represent one of the activation processes of latent HIV-1 in infected patients. Patients presumably suffer oxidative stress during the long latency period, so long term treatment of H2O2 of transformed cells may be a useful model for the onset of AIDS by oxidative stress.

Induction of the NF-kappa B DNA Motif-binding Protein in Transformed Cells

Binding proteins of the NF-kappa B DNA motif were detected with a Life Technologies, Inc. kit. A 42-mer DNA containing two GGGGACTTTCC motifs was end-labeled with [gamma -32P]ATP and added to nuclear proteins extracted from transformed cells treated with 5-day intervals of 0.01 mM H2O2 for 25 days and then 0, 0.05, and 0.2 mM of H2O2 for 1 h. Then the labeled 42-mer DNA fragments were separated by electrophoresis and their mobility shifts were examined. The time course of binding to the 42-mer DNA on long term dilute H2O2 treatment of transformed cells was examined for 25 days (Fig. 2A, parts a and b). It was found that the percentage shift of the 42-mer DNA fragment corresponded well with CAT activity in pCD12 transformed cell lines. The same band shift patterns were also obtained in the mutant pCD12 transformed cell line (MOLT4CD*), but the CAT activity of this cell was low (Fig. 2A, cf. Fig. 1B). These shifted bands disappeared on addition of 50-fold excess amounts of unlabeled 42-mer DNA fragments, but not on addition of 25-fold excess of unlabeled mutant NF-kappa B motif (Fig. 2A, part a). When the above treated cells were also pretreated with NAC (20 mM), the shifted bands decreased in intensity or disappeared (Fig. 2B). On treatment with NAC, the percentage shift of the labeled 42-mer DNA fragment also corresponded with the CAT activity in pCD12 transformed cell lines (Fig. 2B, cf. Fig. 1C). The shifted bands from nuclear extract of 0.2 mM H2O2-treated cells were also supershifted by antisera against NF-kappa B p65 protein, and several supershifted bands appeared (in Fig. 2B). These results suggest that pCD12 transformed cells potentially produce an NF-kappa B-like transcription activating factor by long term dilute H2O2 treatment, corresponding with the CAT activity.


Fig. 2. Induction of NF-kappa B DNA motif-binding protein in pCD12-transformed cells. A, time course of binding of the 42-mer NF-kappa B DNA binding motif with nuclear proteins of transformed cells with long term dilute H2O2 treatment. Part a, a 42-mer DNA was end-labeled and used for band shift assay. open circle , with 50-fold excess of unlabeled 42-mer DNA added during the band shift assay. bullet , with 25-fold excess of unlabeled mutant NF-kappa B motif added during the band shift assay. The arrowhead indicates the shifted bands; part b, the percentage shift of the complex of 42-mer DNA and nuclear proteins. B, reduction of 42-mer shifted band by NAC (20 mM) treatment after long term (25 days) dilute H2O2 (LDH) treatment. Part a, a 42-mer DNA was end-labeled and used for band shift assay. bullet , supershift assay of 42-mer DNA. A single arrowhead indicates the shifted bands, and a double arrowhead indicates supershift bands; part b, the percentage shift of the complex of 42-mer DNA and nuclear proteins. The total percentage shift and the (percentage supershift) are shown in supershift lane. The percentage shift of the DNA-protein complex was calculated as follows; Shift (%) = counts/min of shifted band/total counts/min × 100.
[View Larger Version of this Image (50K GIF file)]

Binding of the NF-kappa B-like Factor to HIV-LTR DNA in Transformed Cells

To examine the binding activity of the NF-kappa B-like factor with the transcription-activating motif in HIV-1-LTR, a SacI,PvuII fragment (120 bp) containing the NF-kappa B binding DNA motif of HIV-1-LTR (20) was isolated, end-labeled, and incubated with nuclear proteins of transformed cell lines. The time courses of mobility shift on long term dilute H2O2 treatment (Fig. 3A) and NAC treatment (Fig. 3B) were also examined. Essentially the same results were obtained as with the 42-mer NF-kappa B DNA binding motif (Fig. 3, cf. Fig. 2). After band shift assay, shifted bands (except supershifted bands) were eluted from the gel and then DNA-protein complexes were immunoprecipitated with anti-NF-kappa B p65 rabbit serum. The recoveries of radioactivity from shifted bands of transformed cells were about 75% or more. These results also strongly suggest that pCD12-transformed cell lines potentially produce an NF-kappa B-like transcription-activating factor (which could bind to the HIV-LTR region) on long term dilute H2O2 treatment corresponding with the CAT activity.


Fig. 3. Binding of HIV-LTR fragments with nuclear proteins of pCD12-transformed cell lines. A, time course of binding of HIV-LTR DNA fragments with nuclear proteins of transformed cells with long term dilute H2O2 treatment (LDH). Part a, a SacI and PvuII fragment of HIV-1-LTR DNA (120 bp) was end-labeled and used for binding assays. open circle , with 50-fold excess of unlabeled 120-bp DNA added during the band shift assay. bullet , with 25-fold excess of unlabeled mutant NF-kappa B motif added during the band shift assay. The arrowhead indicates the shifted bands; part b, the percentage shift of the complex of 120-bp DNA and nuclear proteins (cf. Fig. 2). B, reduction of 120-bp shifted band by NAC (20 mM) treatment after long term (25 days) dilute H2O2 (LDH) treatment. Part a, a 120-bp DNA fragment was end-labeled and used for band shift and supershift assay; part b, the percentage shift of the complex of 120-bp DNA and nuclear proteins (cf. Fig. 2).
[View Larger Version of this Image (50K GIF file)]

The transformed cells showed a latency for production of CAT activity, but when these cells were maintained in the medium with a low concentration of H2O2, they became potent producers of an NF-kappa B-like factor, and the HIV-1 promoter was activated by even a moderate concentration of short term H2O2 treatment. Patients infected with HIV-1 show a latency for a long time. The latency for the production of HIV-1 in transformed cell seems to correspond well with the latency of the cells of infected patients (8, 9). It is interesting that the activation of transformed cells by treatment with a low concentration of H2O2 for a long time seems to correspond with the activation of the latent HIV-1 virus in patients. Physical movement and normal metabolism should cause various types of oxygen stress in the body (9). As in transformed cells, this oxygen stress over a long period may result in activation of the latent virus by NF-kappa B. Therefore, the present cell system may be a useful model of HIV-1 virus activation and production of AIDS.


FOOTNOTES

*   This work is supported by a grant from Ministry of Health and Welfare, Research Committee on Prevention of Developing Illnesses and Therapy for HIV Infected Patients. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1   The abbreviations used are: HIV-1, human immunodeficiency virus 1; CAT, chloramphenicol acetyltransferase; H2O2, hydrogen peroxide; LDH, long term dilute H2O2; NAC, N-acetyl-L-cysteine; LTR, long terminal repeat; bp, base pairs.

Acknowledgments

We thank Drs. F. Wong-Staal and T. Okamoto for gifts of plasmid pCD12.


REFERENCES

  1. Blatter, W. A., Biggar, R. J., Weiss, S. H., Melbye, M., Goedert, J. J. (1985) Ann. Intern. Med. 103, 665-669
  2. Fauci, A. S. (1993) N. Engl. J. Med. 328, 429-436 [Free Full Text]
  3. Weiss, R. A. (1993) Science 260, 1273-1279 [Abstract/Free Full Text]
  4. Mosca, J. D., Bednarik, D. P., Raj, N. B. K., Rosen, C. A., Sodroski, J. G., Haseltine, W. A., Pitha, P. M. (1987) Nature 325, 67-70 [CrossRef][Medline] [Order article via Infotrieve]
  5. Nabel, G., Baltimore, D. (1987) Nature 326, 711-713 [CrossRef][Medline] [Order article via Infotrieve]
  6. Schreck, R., Rieber, P., Baeuerle, A. (1991) EMBO J. 10, 2247-2258 [Medline] [Order article via Infotrieve]
  7. Kurata, S-I. (1994) J. Biol. Chem. 269, 24553-24556 [Abstract/Free Full Text]
  8. Fridovich, I. (1975) Annu. Rev. Biochem. 44, 147-159 [CrossRef][Medline] [Order article via Infotrieve]
  9. Hayaishi, O., Ueda, K. (1997) Annu. Rev. Biochem. 46, 95-116 [CrossRef]
  10. Nabel, G., Baltimore, D. (1987) Nature 326, 711-713
  11. Osborn, L., Kunkel, S., Nabel, G. J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2336-2340 [Abstract/Free Full Text]
  12. Gorman, C., Moffat, L., Howard, B. (1982) Mol. Cell Biol. 2, 1044-1051 [Abstract/Free Full Text]
  13. Southern, P. J., Berg, P. (1982) J. Mol. Appl. Genet. 1, 327-332 [Medline] [Order article via Infotrieve]
  14. Okamoto, T., Wong-Staal, F. (1986) Cell 47, 29-35 [CrossRef][Medline] [Order article via Infotrieve]
  15. Sandri-Goldin, R. M., Goldin, A. L., Levine, M., Glorioso, J. C. (1981) Mol. Cell. Biol. 1, 743-752 [Abstract/Free Full Text]
  16. Kurata, S-I., Wakabayashi, T., Ito, Y., Miwa, N., Ueno, R., Marumouchi, T., Kurata, N. (1993) FEBS Lett. 321, 201-204 [CrossRef][Medline] [Order article via Infotrieve]
  17. Dignam, J. D., Lebowiz, E. F., Roeder, R. G. (1983) Nucleic Acids Res. 11, 1475-1486 [Abstract/Free Full Text]
  18. Lenardo, M. J., Fan, C. M., Maniatis, T., Baltimore, O. (1989) Cell 57, 287-294 [CrossRef][Medline] [Order article via Infotrieve]
  19. Metzger, S., Halaas, J. L., Breslow, J. L., Sladek, F. M. (1993) J. Biol. Chem. 268, 16831-16838 [Abstract/Free Full Text]
  20. Rosen, C. A., Sodroski, J. G., Haseltine, W. A. (1985) Cell 41, 813-823 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Katoh, Y. Tomimori, Y. Ikawa, and S.-i. Kurata
Dimerization and Processing of Procaspase-9 by Redox Stress in Mitochondria
J. Biol. Chem., April 9, 2004; 279(15): 15515 - 15523.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. A. Davis, K. Yusa, L. A. Gillim, F. M. Newcomb, H. Mitsuya, and R. Yarchoan
Conserved Cysteines of the Human Immunodeficiency Virus Type 1 Protease Are Involved in Regulation of Polyprotein Processing and Viral Maturation of Immature Virions
J. Virol., February 1, 1999; 73(2): 1156 - 1164.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. A. Davis, F. M. Newcomb, D. W. Starke, D. E. Ott, J. J. Mieyal, and R. Yarchoan
Thioltransferase (Glutaredoxin) Is Detected Within HIV-1 and Can Regulate the Activity of Glutathionylated HIV-1 Protease in Vitro
J. Biol. Chem., October 10, 1997; 272(41): 25935 - 25940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-i. Kurata
Selective Activation of p38 MAPK Cascade and Mitotic Arrest Caused by Low Level Oxidative Stress
J. Biol. Chem., July 28, 2000; 275(31): 23413 - 23416.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurata, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurata, S.-i.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.